348 related articles for article (PubMed ID: 23647276)
1. Therapeutic potential of cell-penetrating peptides.
Vasconcelos L; Pärn K; Langel U
Ther Deliv; 2013 May; 4(5):573-91. PubMed ID: 23647276
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic applications of cell-penetrating peptides.
Johnson RM; Harrison SD; Maclean D
Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides as a novel transdermal drug delivery system.
Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating peptides for drug delivery across membrane barriers.
Foged C; Nielsen HM
Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
[TBL] [Abstract][Full Text] [Related]
5. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
6. Cell entry of cell penetrating peptides: tales of tails wagging dogs.
Jones AT; Sayers EJ
J Control Release; 2012 Jul; 161(2):582-91. PubMed ID: 22516088
[TBL] [Abstract][Full Text] [Related]
7. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes.
Hansen MB; van Gaal E; Minten I; Storm G; van Hest JC; Löwik DW
J Control Release; 2012 Nov; 164(1):87-94. PubMed ID: 23085152
[TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
9. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.
Borrelli A; Tornesello AL; Tornesello ML; Buonaguro FM
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385037
[TBL] [Abstract][Full Text] [Related]
10. In vivo biodistribution and efficacy of peptide mediated delivery.
Järver P; Mäger I; Langel Ü
Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptides, electroporation and drug delivery.
Cahill K
IET Syst Biol; 2010 Nov; 4(6):367-78. PubMed ID: 21073236
[TBL] [Abstract][Full Text] [Related]
12. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
Gooding M; Browne LP; Quinteiro FM; Selwood DL
Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
[TBL] [Abstract][Full Text] [Related]
13. [Cell penetrating peptides in cancer therapy].
Huang S; Liu YW; Jiang Y
Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):301-6. PubMed ID: 18232298
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides: breaking through to the other side.
Koren E; Torchilin VP
Trends Mol Med; 2012 Jul; 18(7):385-93. PubMed ID: 22682515
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin.
Li Y; Zheng X; Cao Z; Xu W; Zhang J; Gong M
Int J Pharm; 2012 Sep; 434(1-2):209-14. PubMed ID: 22688249
[TBL] [Abstract][Full Text] [Related]
16. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
[TBL] [Abstract][Full Text] [Related]
17. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides can confer biological function: regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides.
Brugnano JL; Chan BK; Seal BL; Panitch A
J Control Release; 2011 Oct; 155(2):128-33. PubMed ID: 21600941
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
20. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.
Ryu JS; Kuna M; Raucher D
Ther Deliv; 2014 Apr; 5(4):429-45. PubMed ID: 24856169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
